Management team

Johan Källstrand
CEO 

Co-founder of several companies within biotech, extensive knowledge in medtech product development, IP, strategy and finance. Commercialized several innovations with experience from both IPO and industry sales. Proven ability to commercialize projects

Daniel Ansari 
Scientific Coordinator & co-founder

Researcher and associate professor (surgery) at Lund University, as well as surgeon at SUS, Skåne University Hospital.  He has extensive research experience in the field of surgery and diagnostics, with special focus on translational research in pancreatic cancer.

Roland Andersson
Chairman & founder

Professor of surgery, Faculty of Medicine at Lund University. He is founder of Reccan Diagnostics AB, as well as other biotech companies. Extensive research and clinical experience.

Board members

Roland Andersson (Chairman)

Professor of surgery, Faculty of Medicine at Lund University. He is founder of Reccan Diagnostics AB, as well as other biotech companies. Extensive research and clinical experience.

Christer Fåhraeus 

CEO of EQL Pharma AB and a serial entrepreneur, having founded and developed several successful companies in biotech and engineering. He is Chairman of the board of FlatFrog Laboratories AB, Longboat explorers AB and Respiratorius, as well as board member in CellaVision AB and EQL Pharma AB.

BG Svensson

Experienced Chairman with a demonstrated history of working in the research industry. Skilled in Sustainable Development, Business Planning, Analytical Skills, Innovation Management, and Entrepreneurship. Strong entrepreneurship professional graduated from Lunds universitet.

Christine Widstrand

Christine Widstrand is Executive Vice President at LU Innovation System AB and responsible for the Life Science portfolio. She holds a PhD in Analytical Chemistry from Lund University. With a background as CEO and founder of several Biotech Companies.

Daniel Ansari

Researcher and associate professor (surgery) at Lund University, as well as surgeon at SUS, Skåne University Hospital.  He has extensive research experience in the field of surgery and diagnostics, with special focus on translational research in pancreatic cancer.

György Marko-Varga

Professor and head of the division of clinical protein science and imaging at Lund University, professor at Tokyo Medical University in Japan. He has almost twenty years of experience from Big Pharma, patent applications, novel technological platforms and biobanking.

Reccan Diagnostics AB

Org no. 556985-4192